Category: Federal Forum Posters
Purpose: The purpose of this quality improvement assessment is to educate providers, through academic detailing, on the importance of recognizing Opioid Use Disorder (OUD) and providing naloxone, and to evaluate the effect on the providers’ prescribing patterns for naloxone at the hospital. OUD has emerged as a major issue and opioid overuse and misuse commonly leads to fatal overdoses. OUD can develop after repeated opioid use and requires chronic management. Naloxone, which is used to treat opioid overdose in emergency situations, can help prevent fatalities when an overdose occurs, especially in patients with OUD.
Methods: Beginning October 1, 2018, patients with Opioid Use Disorder (OUD), as determined by chart reviews, will be randomly selected and their primary provider will be contacted for education outreach. Education will be provided to those contacted providers on recognizing Opioid Use Disorder (OUD) and the importance of patients with OUD having naloxone on hand for emergency situations. A pamphlet will be made with information about OUD and how to use naloxone, which the providers can make available to their patients. Inclusion criteria consists of all patients diagnosed with OUD at the hospital. There are no exclusion criteria to allow for a greater outreach to providers and their patients. The primary endpoint is the difference in number of naloxone prescriptions from the beginning to the end of the six-month assessment. The secondary endpoint is the reduction in number of opioid prescriptions prescribed from the beginning to the end of the assessment.
Results: Not applicable
Conclusion: Not applicable
Jane You– Pharmacy Resident, Northport Veterans Affairs Medical Center, Brooklyn, NY